6631 - 6640 of 9140 Results
Title
Year
- β2‐adrenoreceptor medications and risk of Parkinson disease2018RESTRICTEDTitle: β2‐adrenoreceptor medications and risk of Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 84Issue #: 5Start Page: 683End Page: 693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25341Citation Count: 86
-
OPENTitle: Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and InternalizationJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 291Issue #: 9Start Page: 4374End Page: 4385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.m115.705095Best OA location URL: http://www.jbc.org/article/S0021925820435859/pdfCitation Count: 165
-
OPENTitle: Excess risk of fracture in incident Parkinson’s disease Medicare beneficiariesJournal Name: Injury EpidemiologyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 4End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s40621-025-00643-4Best OA location URL: https://link.springer.com/content/pdf/10.1186/s40621-025-00643-4.pdfCitation Count: 0
-
OPENTitle: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 69Issue #:Start Page: 102474End Page: 102474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474Best OA location URL: http://www.thelancet.com/article/S2589537024000531/pdfCitation Count: 26
-
RESTRICTEDTitle: A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal InterneuronsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 2Start Page: 306End Page: 319Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00329Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5924706Citation Count: 53
-
OPENTitle: Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 5Start Page: 893End Page: 906Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25897Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25897Citation Count: 110
- Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned rats2011RESTRICTEDTitle: Retigabine, a KV7 (KCNQ) potassium channel opener, attenuates l-DOPA-induced dyskinesias in 6-OHDA-lesioned ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 62Issue #: 2Start Page: 1052End Page: 1061Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2011.10.016Citation Count: 24
- Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrain2014OPENTitle: Recombinant adenoassociated virus 2/5-mediated gene transfer is reduced in the aged rat midbrainJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 2Start Page: 1110End Page: 1120Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.047Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.07.047Citation Count: 22
- Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease2018OPENTitle: Sex differences in progression to mild cognitive impairment and dementia in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 50Issue #:Start Page: 29End Page: 36Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5943177Citation Count: 141
-
OPENTitle: Rab29 activation of the Parkinson's disease‐associated LRRK2 kinaseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 37Issue #: 1Start Page: 1End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embj.201798099Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embj.201798099Citation Count: 373